Talk:2011 Group Project 2

From Embryology

Group 2: User:z3279511 | User:z3288196 | User:z3288729 | User:z3288827


--Mark Hill 07:35, 30 September 2011 (EST) Currently all students originally assigned to each group are listed as equal authors/contributors to their project. If you have not contributed the content you had originally agreed to, nor participated in the group work process, then you should contact the course coordinator immediately and either discuss your contribution or request removal from the group author list. Remember that all student online contributions are recorded by date, time and the actual contributed content. A similar email reminder will be sent to all current students.

Please note the Universities Policy regarding Plagiarism

In particular this example:

"Claiming credit for a proportion of work contributed to a group assessment item that is greater than that actually contributed;"

Academic Misconduct carries penalties. If a student is found guilty of academic misconduct, the penalties include warnings, remedial educative action, being failed in an assignment or excluded from the University for two years.

2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip

Week 3 references

Review Article

Hey guys, just found a review article that I thought was rather interesting, it's an animal model for Duchenne's muscular dystrophy[1]. I also found a primary journal article that discusses drug delivery for the condition [2]. I will print these articles for myself tonight and give them a quick read tomorrow and then paste a quick summary of the articles here just for you guys to consider :)

Review Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications.

Primary Detection of duchenne/becker muscular dystrophy carriers in a group of Iranian families by linkage analysis.

--Sarah Jenkins 10:00, 6 August 2011 (EST)

Primary Diagnosis and management of Duchenne muscular dystrophy in a developing country over a 10-year period.

Review Advances in Duchenne muscular dystrophy gene therapy.

--Anna Marx 12:52, 8 August 2011 (EST)

More Articles

Hello! Those articles above look great. From the little research I have done it looks like there is plenty of research to choose from, so that makes our job a little easier I hope. The primary journal article I found talks about the expression of the DMD Gene Products in Embryonic Stem Cells, so hoping that this will allow us to elaborate a bit on the genetic aspects of the development and potential early identification, as symptoms do not usually appear in humans until a few years of age [3]. Also the review article I found refers to two other types of muscular dystrophies as well as DMD (SCARMD, CMD), highlighting many key developments in research. Seem to be very informative, also refers a bit to the importance of animal models in these developments [4].

--Z3288196 12:19, 11 August 2011 (EST)

Reference List